Hyderabad-based Bharat Biotech on Sunday issued a clarification that there is "no impact on efficacy and safety of the Covid-19 vaccine COVAXIN" after the World Health Organisation suspended it from its Covax facility. "For the millions who have received COVAXIN, the vaccine certificates issued still stand valid as there is no impact on efficacy and safety of the vaccine," read the statement issued by Bharat Biotech on suspension from WHO.

The vaccine manufacturer has further said that the company is slowing down the production of Covaxin for facility optimization. "For the coming period the company will focus on pending facility maintenance, process and facility optimization activities," the statement read.